MTB0 Stock Chart & Stats
€1.94
>-€0.01(-0.22%)
At close: 4:00 PM EDT
€1.94
>-€0.01(-0.22%)
Day’s Range― - ―
52-Week Range€1.41 - €3.18
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€66.74M
Enterprise Value€130.71M
Total Cash (Recent Filing)€13.39M
Total Debt (Recent Filing)€54.01M
Price to Earnings (P/E)25.2
Beta0.62
Next Earnings
Nov 05, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding42,493,860
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)2.08
Price to Sales (P/S)1.03
P/FCF Ratio6.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.14Price Target Upside268.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.24
Revenue Forecast (FY)€116.15M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue ExpansionA rising recurring-revenue mix improves visibility and makes growth less dependent on one-time projects. Expansion within the provider base can support steadier cash generation, strengthen customer relationships, and create a durable platform for cross-selling software and services.
Profitability And Cash GenerationSustained GAAP profitability alongside substantial free cash flow indicates that the operating model is producing cash rather than relying solely on accounting adjustments. This supports continued product investment, acquisition funding, and greater financial resilience over coming quarters.
Product And Market ExpansionAdding compliance and audit-defense capabilities broadens CareCloud’s addressable workflow and gives it another service to sell to existing healthcare-provider customers. Converting that expertise into subscription software could deepen recurring revenue and increase platform value over time.
Bears Say
Profitability PressureThe sharp earnings decline shows that higher R&D, acquisition integration, amortization, and interest costs are currently absorbing part of the company’s growth. If investment spending does not translate into sufficient scale, margin recovery and earnings compounding could remain delayed.
Balance-Sheet VolatilityAlthough current leverage is described as manageable, rising debt and a smaller equity base reduce protection against operating setbacks. This can increase sensitivity to execution or accounting swings and limit flexibility while CareCloud funds integration, product development, and growth.
Integration And Execution RiskThe growth plan relies on integrating acquisitions, controlling expenses, retaining or signing clients, and launching AI and compliance products on schedule. Delays or weaker adoption could postpone expected scale benefits and keep costs elevated beyond the near term.
CareCloud News
MTB0 FAQ
What was CareCloud’s price range in the past 12 months?
CareCloud lowest stock price was €1.41 and its highest was €3.17 in the past 12 months.
What is CareCloud’s market cap?
CareCloud’s market cap is €66.74M.
When is CareCloud’s upcoming earnings report date?
CareCloud’s upcoming earnings report date is Nov 05, 2026 which is in 4 days.
How were CareCloud’s earnings last quarter?
CareCloud released its earnings results on Aug 06, 2026. The company reported €0 earnings per share for the quarter, missing the consensus estimate of €0.021 by -€0.021.
Is CareCloud overvalued?
According to Wall Street analysts CareCloud’s price is currently Undervalued.
Does CareCloud pay dividends?
CareCloud does not currently pay dividends.
What is CareCloud’s EPS estimate?
CareCloud’s EPS estimate is 0.09.
How many shares outstanding does CareCloud have?
CareCloud has 42,493,860 shares outstanding.
What happened to CareCloud’s price movement after its last earnings report?
CareCloud reported an EPS of €0 in its last earnings report, missing expectations of €0.021. Following the earnings report the stock price went down -2.713%.
Which hedge fund is a major shareholder of CareCloud?
Currently, no hedge funds are holding shares in DE:MTB0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CareCloud Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€7.14 (268.00% Upside)
€7.14 (268.00% Upside)
Blogger Sentiment
Neutral
DE:MTB0 Sentiment 50%
Sector Average 64%
Sector Average 64%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-41.52%
12-Months-Change
Fundamentals
Return on Equity
16.56%
Trailing 12-Months
Asset Growth
24.73%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
CareCloud
CareCloud, Inc. operates as a specialized healthcare technology firm, delivering a comprehensive portfolio of cloud-powered solutions and related professional services. Its primary clientele consists of medical providers and hospitals throughout the United States. The company strategically organizes its activities into two core divisions: Healthcare IT and Medical Practice Management. Through its Software-as-a-Service (SaaS) platform, CareCloud provides essential tools for managing revenue cycles, administering practices, handling electronic health records, gleaning business insights, facilitating telehealth, and enhancing patient engagement. These offerings, complemented by various software utilities and tailored business services, are designed to empower diverse medical groups and health systems. Professionals such as doctors, nurses, physician assistants, and other clinical staff who render billable services are among its key users. Established in 1999 and based in Somerset, New Jersey, the entity was originally named MTBC, Inc. before officially adopting CareCloud, Inc. in March 2021.
MTB0 Company Deck
MTB0 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a constructive, strategic story: solid top-line growth (+16% Q2, +15% H1), a growing recurring revenue mix, continued GAAP profitability streak, a cleaner capital structure after fully redeeming Series B, and clear progress on AI and a new compliance SaaS initiative. Near-term reported profitability and some cash metrics are pressured by deliberate investment choices — accelerated R&D expense, acquisition-related amortization, and higher interest — and by integration work (notably Medsphere). Management reaffirmed guidance and expects a stronger second half as investments convert to scale. Overall, positives (revenue/regional trends, recurring revenue expansion, capital structure improvement, AI/product milestones, new market entry) outweigh the near-term headwinds driven by strategic investments and integration costs, but execution risk remains.View all DE:MTB0 earnings summariesMTB0 Stock 12 Month Forecast
Average Price Target
€7.14
▲(268.00% Upside)
Technical Analysis
Evolent Health
―
Phreesia
―
Health Catalyst
―
American Well
―
Waystar Holding Corp.
―